Coagulation in inflammatory diseases of the central nervous system

Seminars in Thrombosis and Hemostasis

Volumn 39, Issue 8, 2013, Pages 876-880

  Chapman, Joab ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

antiphospholipid syndrome; conduction block; multiple sclerosis; synaptic function; thrombin

Indexed keywords

DERMATAN SULFATE; DROTRECOGIN; HEPARIN; HIRUDIN; PROTEINASE ACTIVATED RECEPTOR 1;

ALLERGIC ENCEPHALOMYELITIS; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CLOTTING; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFLAMMATORY DISEASE; DEMYELINATION; GUILLAIN BARRE SYNDROME; HEMOSTASIS; HUMAN; INFLAMMATORY DISEASE; LONG TERM POTENTIATION; LUPUS VULGARIS; MULTIPLE SCLEROSIS; NERVE CONDUCTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; THROMBOSIS; UPREGULATION;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BRAIN; ENCEPHALITIS; HUMANS; LONG-TERM POTENTIATION; MODELS, BIOLOGICAL; RECEPTOR, PAR-1; SIGNAL TRANSDUCTION;

EID: 84887056381     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1357482     Document Type: Article

References (75)

1. Deschepper C. F., Bigornia V., Berens M. E., Lapointe M. C. Production of thrombin and antithrombin III by brain and astroglial cell cultures. Brain Res Mol Brain Res: 1991; 11 3-4 355 358
2. Dihanich M., Kaser M., Reinhard E., Cunningham D., Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron: 1991; 6 4 575 581
3. Ferland G. Vitamin K, an emerging nutrient in brain function. Biofactors: 2012; 38 2 151 157
4. Davalos D., Ryu J. K., Merlini M., et al. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun: 2012; 3 1227
5. Davalos D., Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol: 2012; 34 1 43 62
6. Ryu J. K., Davalos D., Akassoglou K. Fibrinogen signal transduction in the nervous system. J Thromb Haemost: 2009; 7 01 151 154
7. Mullins E. S., Kombrinck K. W., Talmage K. E., et al. Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain. Blood: 2009; 113 3 696 704
8. Bar-Shavit R., Hruska K. A., Kahn A. J., Wilner G. D. Hormone-like activity of human thrombin. Ann N Y Acad Sci: 1986; 485 335 348
9. Coughlin S. R. Thrombin signalling and protease-activated receptors. Nature: 2000; 407 6801 258 264
10. Weinstein J. R., Zhang M., Kutlubaev M., et al. Thrombin-induced regulation of CD95(Fas) expression in the N9 microglial cell line: evidence for involvement of proteinase-activated receptor(1) and extracellular signal-regulated kinase 1/2. Neurochem Res: 2009; 34 3 445 452
11. Möller T., Weinstein J. R., Hanisch U. K. Activation of microglial cells by thrombin: past, present, and future. Semin Thromb Hemost: 2006; 32 01 69 76
12. Hanisch U. K., van Rossum D., Xie Y., et al. The microglia-activating potential of thrombin: the protease is not involved in the induction of proinflammatory cytokines and chemokines. J Biol Chem: 2004; 279 50 51880 51887
13. Möller T., Hanisch U. K., Ransom B. R. Thrombin-induced activation of cultured rodent microglia. J Neurochem: 2000; 75 4 1539 1547
14. Gurwitz D., Cunningham D. D. Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc Natl Acad Sci U S A: 1988; 85 10 3440 3444
15. Cunningham D. D., Donovan F. M. Regulation of neurons and astrocytes by thrombin and protease nexin-1. Relationship to brain injury. Adv Exp Med Biol: 1997; 425 67 75
16. Schmidlin F., Bunnett N. W. Protease-activated receptors: how proteases signal to cells. Curr Opin Pharmacol: 2001; 1 6 575 582
17. Vu T. K., Hung D. T., Wheaton V. I., Coughlin S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell: 1991; 64 6 1057 1068
18. Déry O., Corvera C. U., Steinhoff M., Bunnett N. W. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol: 1998; 274 6, Pt 1 C1429 C1452
19. Donovan F. M., Cunningham D. D. Signaling pathways involved in thrombin-induced cell protection. J Biol Chem: 1998; 273 21 12746 12752
20. Pike C. J., Vaughan P. J., Cunningham D. D., Cotman C. W. Thrombin attenuates neuronal cell death and modulates astrocyte reactivity induced by beta-amyloid in vitro. J Neurochem: 1996; 66 4 1374 1382
21. Festoff B. W., Smirnova I. V., Ma J., Citron B. A. Thrombin, its receptor and protease nexin I, its potent serpin, in the nervous system. Semin Thromb Hemost: 1996; 22 3 267 271
22. Cirino G., Cicala C., Bucci M. R., Sorrentino L., Maraganore J. M., Stone S. R. Thrombin functions as an inflammatory mediator through activation of its receptor. J Exp Med: 1996; 183 3 821 827
23. Lee K. R., Drury I., Vitarbo E., Hoff J. T. Seizures induced by intracerebral injection of thrombin: a model of intracerebral hemorrhage. J Neurosurg: 1997; 87 1 73 78
24. Xue M., Del Bigio M. R. Acute tissue damage after injections of thrombin and plasmin into rat striatum. Stroke: 2001; 32 9 2164 2169
25. Lee K. R., Colon G. P., Betz A. L., Keep R. F., Kim S., Hoff J. T. Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg: 1996; 84 1 91 96
26. Aronovich R., Gurwitz D., Kloog Y., Chapman J. Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms. Immunobiology: 2005; 210 10 781 788
27. Alabanza L. M., Bynoe M. S. Thrombin induces an inflammatory phenotype in a human brain endothelial cell line. J Neuroimmunol: 2012; 245 1-2 48 55
28. Menachem A., Chapman J., Katzav A. Significant changes in the levels of secreted cytokines in brains of experimental antiphospholipid syndrome mice. Autoimmune Dis: 2012; 2012 404815
29. Tanne D., Katzav A., Beilin O., et al. Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome. Neurobiol Dis: 2008; 30 1 56 64
30. Katzav A., Grigoriadis N. C., Ebert T., et al. Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice. BMC Med: 2013; 11 92
31. Katzav A., Kivity S., Blank M., Shoenfeld Y., Chapman J. Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome. Lupus: 2012; 21 2 210 216
32. Frauenknecht K., Katzav A., Grimm C., Chapman J., Sommer C. J. Neurological impairment in experimental antiphospholipid syndrome is associated with increased ligand binding to hippocampal and cortical serotonergic 5-HT1A receptors. Immunobiology: 2013; 218 4 517 526
33. Katzav A., Litvinjuk Y., Pick C. G., et al. Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome. Behav Brain Res: 2006; 169 2 289 293
34. Katzav A., Pick C. G., Korczyn A. D., et al. Hyperactivity in a mouse model of the antiphospholipid syndrome. Lupus: 2001; 10 7 496 499
35. Shrot S., Katzav A., Korczyn A. D., et al. Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus: 2002; 11 11 736 743
36. Rosidi N. L., Zhou J., Pattanaik S., et al. Cortical microhemorrhages cause local inflammation but do not trigger widespread dendrite degeneration. PLoS ONE: 2011; 6 10 e26612
37. Giwa M. O., Williams J., Elderfield K., et al. Neuropathologic evidence of endothelial changes in cerebral small vessel disease. Neurology: 2012; 78 3 167 174
38. Cicala C., Cirino G. Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk. Life Sci: 1998; 62 20 1817 1824
39. Esmon C. T. Role of coagulation inhibitors in inflammation. Thromb Haemost: 2001; 86 1 51 56
40. Miller K. D., Phelan A. W., Collins D. N. Prothrombin activation by encephalitogenic brain protein. Exp Mol Pathol: 1966; 5 6 575 579
41. Koh C. S., Gausas J., Paterson P. Y. Concordance and localization of maximal vascular permeability change and fibrin deposition in the central neuraxis of Lewis rats with cell-transferred experimental allergic encephalomyelitis. J Neuroimmunol: 1992; 38 1-2 85 93
42. Inaba Y., Ichikawa M., Inoue A., et al. Plasma thrombin-antithrombin III complex is associated with the severity of experimental autoimmune encephalomyelitis. J Neurol Sci: 2001; 185 2 89 93
43. Beilin O., Gurwitz D., Korczyn A. D., Chapman J. Quantitative measurements of mouse brain thrombin-like and thrombin inhibition activities. Neuroreport: 2001; 12 11 2347 2351
44. Guenther J., Nick H., Monard D. A glia-derived neurite-promoting factor with protease inhibitory activity. EMBO J: 1985; 4 8 1963 1966
45. Gloor S., Odink K., Guenther J., Nick H., Monard D. A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins. Cell: 1986; 47 5 687 693
46. Reinhard E., Suidan H. S., Pavlik A., Monard D. Glia-derived nexin/protease nexin-1 is expressed by a subset of neurons in the rat brain. J Neurosci Res: 1994; 37 2 256 270
47. Wagner S. L., Geddes J. W., Cotman C. W., et al. Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease. Proc Natl Acad Sci U S A: 1989; 86 21 8284 8288
48. Kalaria R. N., Golde T., Kroon S. N., Perry G. Serine protease inhibitor antithrombin III and its messenger RNA in the pathogenesis of Alzheimer's disease. Am J Pathol: 1993; 143 3 886 893
49. Deschepper C. F., Bigornia V., Berens M. E., Lapointe M. C. Production of thrombin and antithrombin III by brain and astroglial cell cultures. Brain Res Mol Brain Res: 1991; 11 3-4 355 358
50. Beilin O., Karussis D. M., Korczyn A. D., et al. Increased thrombin inhibition in experimental autoimmune encephalomyelitis. J Neurosci Res: 2005; 79 3 351 359
51. Beilin O., Karussis D. M., Korczyn A. D., et al. Increased KPI containing amyloid precursor protein in experimental autoimmune encephalomyelitis brains. Neuroreport: 2007; 18 6 581 584
52. Chelmicka-Szorc E., Arnason B. G. Partial suppression of experimental allergic encephalomyelitis with heparin. Arch Neurol: 1972; 27 2 153 158
53. Inaba Y., Ichikawa M., Koh C. S., et al. Suppression of experimental autoimmune encephalomyelitis by dermatan sulfate. Cell Immunol: 1999; 198 2 96 102
54. Wiedermann ChJ, Römisch J. The anti-inflammatory actions of antithrombin-a review. Acta Med Austriaca: 2002; 29 3 89 92
55. Traugott U., Raine C. S., McFarlin D. E. Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion. Cell Immunol: 1985; 91 1 240 254
56. Cuzner M. L., Opdenakker G. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J Neuroimmunol: 1999; 94 1-2 1 14
57. Teesalu T., Hinkkanen A. E., Vaheri A. Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice. Am J Pathol: 2001; 159 6 2227 2237
58. Kieseier B. C., Seifert T., Giovannoni G., Hartung H. P. Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurology: 1999; 53 1 20 25
59. Suidan H. S., Bouvier J., Schaerer E., Stone S. R., Monard D., Tschopp J. Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes. Proc Natl Acad Sci U S A: 1994; 91 17 8112 8116
60. Eeckhout Y., Vaes G. Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J: 1977; 166 1 21 31
61. Meins M., Piosik P., Schaeren-Wiemers N., et al. Progressive neuronal and motor dysfunction in mice overexpressing the serine protease inhibitor protease nexin-1 in postmitotic neurons. J Neurosci: 2001; 21 22 8830 8841
62. Houenou L. J., Turner P. L., Li L., Oppenheim R. W., Festoff B. W. A serine protease inhibitor, protease nexin I, rescues motoneurons from naturally occurring and axotomy-induced cell death. Proc Natl Acad Sci U S A: 1995; 92 3 895 899
63. Marx J. A new link in the brain's defenses. Science: 1992; 256 5061 1278 1280
64. Campos-de-Magalhães M., de Almeida A. J., Papaiz-Alvarenga R. M., Gadelha T., Morais-de-Sá C. A., Alves-Leon S. V. Normal plasma antithrombin activity in patients with relapsing-remitting and secondary progressive multiple sclerosis. Clin Neurol Neurosurg: 2009; 111 5 407 411
65. Han M. H., Hwang S. I., Roy D. B., et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature: 2008; 451 7182 1076 1081
66. East E., Gverić D., Baker D., Pryce G., Lijnen H. R., Cuzner M. L. Chronic relapsing experimental allergic encephalomyelitis (CREAE) in plasminogen activator inhibitor-1 knockout mice: the effect of fibrinolysis during neuroinflammation. Neuropathol Appl Neurobiol: 2008; 34 2 216 230
67. East E., Baker D., Pryce G., Lijnen H. R., Cuzner M. L., Gverić D. A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis. Am J Pathol: 2005; 167 2 545 554
68. Shavit E., Beilin O., Korczyn A. D., et al. Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block. Brain: 2008; 131 Pt 4 1113 1122
69. Shavit E., Michaelson D. M., Chapman J. Anatomical localization of protease-activated receptor-1 and protease-mediated neuroglial crosstalk on peri-synaptic astrocytic endfeet. J Neurochem: 2011; 119 3 460 473
70. Maggio N., Shavit E., Chapman J., Segal M. Thrombin induces long-term potentiation of reactivity to afferent stimulation and facilitates epileptic seizures in rat hippocampal slices: toward understanding the functional consequences of cerebrovascular insults. J Neurosci: 2008; 28 3 732 736
71. Almonte A. G., Qadri L. H., Sultan F. A., et al. Protease-activated receptor-1 modulates hippocampal memory formation and synaptic plasticity. J Neurochem: 2013; 124 1 109 122
72. Almonte A. G., Sweatt J. D. Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior. Brain Res: 2011; 1407 107 122
73. Maggio N., Blatt I., Vlachos A., Tanne D., Chapman J., Segal M. Treating seizures and epilepsy with anticoagulants? Front Cell Neurosci: 2013; 7 19
74. Maggio N., Itsekson Z., Dominissini D., et al. Thrombin regulation of synaptic plasticity: Implications for physiology and pathology. Exp Neurol: 2013; 247 595 604
75. Maggio N., Cavaliere C., Papa M., Blatt I., Chapman J., Segal M. Thrombin regulation of synaptic transmission: implications for seizure onset. Neurobiol Dis: 2013; 50 171 178